Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis

Human Molecular Genetics

Volumn 19, Issue 6, 2010, Pages 1058-1065

  Apponi, Luciano H ^a   Leung, Sara W ^a   Williams, Kathryn R ^a   Valentini, Sandro R ^b   Corbett, Anita H ^a   Pavlath, Grace K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; POLYADENYLIC ACID BINDING PROTEIN; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; DEVELOPMENTAL GENETICS; GENE FUNCTION; GENE LOSS; IN VITRO STUDY; MOUSE; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN DEPLETION; RNA TRANSPORT;

ANIMALS; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; MICE; MICE, INBRED BALB C; MUSCLE DEVELOPMENT; MYOBLASTS; POLY A; POLY(A)-BINDING PROTEIN I; POLY(A)-BINDING PROTEIN II; POLYADENYLATION; RNA TRANSPORT; RNA, MESSENGER;

MAMMALIA;

EID: 77950686323     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp569     Document Type: Article

References (44)

1. Kuhn, U. and Wahle, E. (2004) Structure and function of poly(A) binding proteins. Biochim. Biophys. Acta, 1678, 67-84.
2. Kuhn, U., Nemeth, A., Meyer, S. and Wahle, E. (2003) The RNA binding domains of the nuclear poly(A)-binding protein. J. Biol. Chem., 278, 16916-16925.
3. Fan, X., Dion, P., Laganiere, J., Brais, B. and Rouleau, G.A. (2001) Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death. Hum. Mol. Genet., 10, 2341-2351.
4. Calado, A., Tome, F.M., Brais, B., Rouleau, G.A., Kuhn, U., Wahle, E. and Carmo-Fonseca, M. (2000) Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. Hum. Mol. Genet., 9, 2321-2328.
5. Calado, A., Kutay, U., Kuhn, U., Wahle, E. and Carmo-Fonseca, M. (2000) Deciphering the cellular pathway for transport of poly(A)-binding protein II. RNA, 6, 245-256.
6. Calado, A. and Carmo-Fonseca, M. (2000) Localization of poly(A)-binding protein 2 (PABP2) in nuclear speckles is independent of import into the nucleus and requires binding to poly(A) RNA. J. Cell Sci., 113, 2309-2318.
7. Brais, B., Bouchard, J.P., Xie, Y.G., Rochefort, D.L., Chretien, N., Tome, F.M., Lafreniere, R.G., Rommens, J.M., Uyama, E., Nohira, O. et al. (1998) Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat. Genet., 18, 164-167.
8. Victor, M., Hayes, R. and Adams, R.D. (1962) Oculopharyngeal muscular dystrophy. A familial disease of late life characterized by dysphagia and progressive ptosis of the evelids. N. Engl. J. Med., 267, 1267-1272.
9. Ruegg, S., Lehky Hagen, M., Hohl, U., Kappos, L., Fuhr, P., Plasilov, M., Muller, H. and Heinimann, K. (2005) Oculopharyngeal muscular dystrophy - an under-diagnosed disorder? Swiss Med. Wkly, 135, 574-586.
10. Van Der Sluijs, B.M., Hoefsloot, L.H., Padberg, G.W., Van Der Maarel, S.M. and Van Engelen, B.G. (2003) Oculopharyngeal muscular dystrophy with limb girdle weakness as major complaint. J. Neurol., 250, 1307-1312.
11. Tome, F.M. and Fardeau, M. (1980) Nuclear inclusions in oculopharyngeal dystrophy. Acta Neuropathol., 49, 85-87.
12. Tome, F.M., Chateau, D., Helbling-Leclerc, A. and Fardeau, M. (1997) Morphological changes in muscle fibers in oculopharyngeal muscular dystrophy. Neuromuscul. Disord., 7 (Suppl. 1), S63-S69.
13. Benoit, B., Mitou, G., Chartier, A., Temme, C., Zaessinger, S., Wahle, E., Busseau, I. and Simonelig, M. (2005) An essential cytoplasmic function for the nuclear poly(A) binding protein, PABP2, in poly(A) tail length control and early development in Drosophila. Dev. Cell, 9, 511-522.
14. Perreault, A., Lemieux, C. and Bachand, F. (2007) Regulation of the nuclear poly(A)-binding protein by arginine methylation in fission yeast. J. Biol. Chem., 282, 7552-7562.
15. Chen, Z., Li, Y. and Krug, R.M. (1999) Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery. EMBO J., 18, 2273-2283.
16. Charge, S.B. and Rudnicki, M.A. (2004) Cellular and molecular regulation of muscle regeneration. Physiol. Rev., 84, 209-238.
17. Horsley, V. and Pavlath, G.K. (2004) Forming a multinucleated cell: molecules that regulate myoblast fusion. Cells Tissues Organs, 176, 67-78.
18. Costelli, P., Almendro, V., Figueras, M.T., Reffo, P., Penna, F., Aragno, M., Mastrocola, R., Boccuzzi, G., Busquets, S., Bonelli, G. et al. (2007) Modulations of the calcineurin/NF-AT pathway in skeletal muscle atrophy. Biochim. Biophys. Acta, 1770, 1028-1036.
19. Kuhn, U., Gundel, M., Knoth, A., Kerwitz, Y., Rudel, S. and Wahle, E. (2009) Poly(A) tail length is controlled by the nuclear poly(A)-binding protein regulating the interaction between poly(A) polymerase and the cleavage and polyadenylation specificity factor. J. Biol. Chem., 284, 22803-22814.
20. Berkes, C.A. and Tapscott, S.J. (2005) MyoD and the transcriptional control of myogenesis. Semin. Cell Dev. Biol., 16, 585-595.
21. Vinciguerra, P. and Stutz, F. (2004) mRNA export: an assembly line from genes to nuclear pores. Curr. Opin. Cell Biol., 16, 285-292.
22. Huang, Y. and Carmichael, G.G. (1996) Role of polyadenylation in nucleocytoplasmic transport of mRNA. Mol. Cell Biol., 16, 1534-1542.
23. Bear, D.G., Fomproix, N., Soop, T., Bjorkroth, B., Masich, S. and Daneholt, B. (2003) Nuclear poly(A)-binding protein PABPN1 is associated with RNA polymerase II during transcription and accompanies the released transcript to the nuclear pore. Exp. Cell Res., 286, 332-344.
24. Lewis, J.D., Gunderson, S.I. and Mattaj, I.W. (1995) The influence of 5' and 3' end structures on pre-mRNA metabolism. J. Cell Sci. Suppl., 19, 13-19.
25. Wickens, M., Anderson, P. and Jackson, R.J. (1997) Life and death in the cytoplasm: messages from the 3' end. Curr. Opin. Genet. Dev., 7, 220-232.
26. Hilleren, P. and Parker, R. (2001) Defects in the mRNA export factors Rat7p, Gle1p, Mex67p, and Rat8p cause hyperadenylation during 3'-end formation of nascent transcripts. RNA, 7, 753-764.
27. Jensen, T.H., Patricio, K., McCarthy, T. and Rosbash, M. (2001) A block to mRNA nuclear export in S. cerevisiae leads to hyperadenylation of transcripts that accumulate at the site of transcription. Mol. Cell, 7, 887-898.
28. Fasken, M.B. and Corbett, A.H. (2009) Mechanisms of nuclear mRNA quality control. RNA Biol., 6, 237-241.
29. Farny, N.G., Hurt, J.A. and Silver, P.A. (2008) Definition of global and transcript-specific mRNA export pathways in metazoans. Genes Dev., 22, 66-78.
30. Keller, R.W., Kuhn, U., Aragon, M., Bornikova, L., Wahle, E. and Bear, D.G. (2000) The nuclear poly(A) binding protein, PABP2, forms an oligomeric particle covering the length of the poly(A) tail. J. Mol. Biol., 297, 569-583.
31. Abu-Baker, A. and Rouleau, G.A. (2007) Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies. Biochim. Biophys. Acta, 1772, 173-185.
32. Abu-Baker, A., Messaed, C., Laganiere, J., Gaspar, C., Brais, B. and Rouleau, G.A. (2003) Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy. Hum. Mol. Genet., 12, 2609-2623.
33. Davies, J.E., Wang, L., Garcia-Oroz, L., Cook, L.J., Vacher, C., O'Donovan, D.G. and Rubinsztein, D.C. (2005) Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice. Nat. Med., 11, 672-677.
34. Davies, J.E., Berger, Z. and Rubinsztein, D.C. (2006) Oculopharyngeal muscular dystrophy: potential therapies for an aggregate-associated disorder. Int. J. Biochem. Cell Biol., 38, 1457-1462.
35. Chartier, A., Benoit, B. and Simonelig, M. (2006) A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1. EMBO J., 25, 2253-2262.
36. Klein, A.F., Ebihara, M., Alexander, C., Dicaire, M.J., Sasseville, A.M., Langelier, Y., Rouleau, G.A. and Brais, B. (2008) PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression. Exp. Cell Res., 314, 1652-1666.
37. Berciano, M.T., Villagra, N.T., Ojeda, J.L., Navascues, J., Gomes, A., Lafarga, M. and Carmo-Fonseca, M. (2004) Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus. Hum. Mol. Genet., 13, 829-838.
38. Brais, B., Rouleau, G.A., Bouchard, J.P., Fardeau, M. and Tome, F.M. (1999) Oculopharyngeal muscular dystrophy. Semin. Neurol., 19, 59-66.
39. Davies, J.E., Sarkar, S. and Rubinsztein, D.C. (2008) Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation. Hum. Mol. Genet., 17, 1097-1108.
40. Perie, S., Mamchaoui, K., Mouly, V., Blot, S., Bouazza, B., Thornell, L.E., St Guily, J.L. and Butler-Browne, G. (2006) Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: Therapeutic perspectives of autologous myoblast transplantation. Neuromuscul. Disord., 16, 770-781.
41. Rando, T.A. and Blau, H.M. (1994) Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol., 125, 1275-1287.
42. Mitchell, P.O. and Pavlath, G.K. (2004) Skeletal muscle atrophy leads to loss and dysfunction of muscle precursor cells. Am. J. Physiol. Cell Physiol., 287, C1753-C1762.
43. Chekanova, J.A., Shaw, R.J. and Belostotsky, D.A. (2001) Analysis of an essential requirement for the poly(A) binding protein function using cross-species complementation. Curr. Biol., 11, 1207-1214.
44. Garneau, N.L., Sokoloski, K.J., Opyrchal, M., Neff, C.P., Wilusz, C.J. and Wilusz, J. (2008) The 3' untranslated region of sindbis virus represses deadenylation of viral transcripts in mosquito and Mammalian cells. J. Virol., 82, 880-892.